Speaker Profile

BIOGRAPHY

Adam Hacker, PhD, is a highly effective leader in the pharmaceutical industry, specializing in regulatory affairs. Since January 2021, Adam has been serving as the Director and Head of Global Regulatory Affairs & Quality at the Coalition for Epidemic Preparedness Innovations (CEPI), a not-for-profit vaccine R&D funding organization. In this role, Adam leads global regulatory networks driving discussion on epidemic and pandemic emergencies and preparedness for future outbreaks and has developed a broad collaborative network of regulatory authorities around the world

With a career driven by increasingly strategic roles, Adam has more than 25 years of experience across a diverse range of departments and therapeutic areas, covering innovative technology and product classes in both regional and global roles. Adam has held senior positions at Autolus Ltd, Janssen (Johnson & Johnson), Biogen Idec, GE Healthcare, and GlaxoSmithKline Pharmaceuticals and has led departments in regulatory affairs, quality and medical affairs.

Adam is also the Chair of the MHRA Review Panel, providing oversight to MHRA decision-making. Additionally, Adam co-chairs the Regulatory Advisory Group alongside the WHO Director of Regulation & Pre-Qualification, working with thirteen regulatory authorities in low-, middle-, and high-income countries to drive alignment and consensus on key COVID- and pandemic preparedness related topics.
An experienced public speaker, panellist, chair, and moderator, Adam has contributed to numerous scientific meetings and conferences. Adam's extensive experience includes providing regulatory oversight to over 70 vaccine development programs, developing CEPI's regulatory pandemic preparedness plan, and driving all vaccine development acceleration initiatives and the 100-day regulatory strategy.

Adam holds a PhD in molecular developmental biology from the National Institute for Medical Research, London. He also earned an MA / BA Degree in Pure and Applied Biology from The Queen's College, Oxford University. Adam has published more than 20 papers.

Most recently Adam was appointed as co-chair of the European Platform for Regulatory Science Research, facilitating collaboration between academic researchers, not-for-profit researchers, regulators, and other stakeholders.